P3 Health Partners Inc. (PIII) Form 8-K — May 15, 2026
P3 Health Partners Inc. (PIII) announced it has regained compliance with Nasdaq’s stockholders’ equity listing requirement, avoiding imminent delisting. The company achieved this by exchanging approximately $252.5 million of outstanding promissory notes held by its largest stockholder, Chicago Pacific Founders, into non-voting, non-convertible preferred stock. Simultaneously, P3 Health closed the first tranche of a $70 million equity offering, raising $30 million through the sale of Series D 19.5% Cumulative Preferred Stock and warrants.
Key figures
- Debt Amount
- 252479967
- Total Assets
- 704157000
- Cash Position
- 55497000
- Gross Proceeds
- 30000000
- Preferred stock rate
- 19.5%
- Nasdaq compliance threshold
- 2500000
- Preferred stock stated value
- 100
- Stockholders equity proforma
- 82114000
Price after filing
Close on the filing date to close N calendar days later (from $4.03). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.